Dan Mercola

Dan Mercola

University of california, USA

Biography
Dr. Mercola is an experienced and innovative translational scientist. In addition to directing Translational Cancer Biology at UC Irvine since 2005, he is PI of the UC Irvine Strategic Partners for the Evaluation of Signatures of Cancer (SPECS) consortium, which liaises with seven external institutes for the development of prognostic biomarkers using genomic methods. Results of these studies have been used for patent filing by UC Irvine and have been exclusively licensed to Proveri Inc., a company cofounded by Dr. Mercola to develop the translation of SPECS IP. Dr. Mercola was also a co-developer of chromatin immunoprecipitation for the analysis of cancer cells. He was selected as “San Diego Padres Medical All-Star” for 2004.  
Research Interest
 chromatin immunoprecipitation for the analysis of cancer cells